The peptide blog.

Most peptide "rankings" sort by hype. This one sorts by what survived a randomized human trial, and the gap between the top and bottom of the board is the most important thing in the field.

It's the internet's favorite "healing peptide", but after 30 years of research, the human evidence base is a single uncontrolled case series of 12 people. Here's the honest gap between the lab and the influencer feed.

A naturally occurring copper-binding tripeptide with a real cosmetic-science pedigree and a long list of inflated claims. Here is what the published research on GHK-Cu actually supports, and where it runs out.

Men increasingly pair growth-hormone peptides with testosterone therapy, but the two systems push on the same bloodwork, the evidence base is uneven, and the only honest answer to "is this safe for me?" lives in your labs.

Four peptides marketed as anti-aging breakthroughs sit at wildly different points on the evidence curve, from a Soviet-era pineal extract to the first mitochondria-targeting drug the FDA ever approved. Here's how to tell the signal from the sales pitch.

It is the one growth-hormone-axis peptide that cleared an FDA trial gauntlet for a fat-loss endpoint, and the fine print is more interesting than the headline.

Retatrutide produced the largest weight reductions ever recorded in a Phase 2 obesity trial. It is also not approved anywhere, and the gap between those two facts is the whole story.

Cycling protocols are stated with the confidence of pharmacology and built with the evidence of folklore. There is one place the concept has real grounding, and it is much narrower than the forums suggest.

Roughly a quarter to a third of the weight lost on GLP-1 drugs is lean mass. That number is real, alarming out of context, and almost identical to what happens with any other method of losing the same amount of weight.

The internet's favorite "healing stack" promises Wolverine-grade recovery, but strip away the forum hype and almost all the data is in rats, not people.

These viral "healing blend" recipes stack four research peptides into one vial, but the evidence behind each ingredient is mostly preclinical, and mixing them doesn't make it stronger.

"Research use only" is a legal disclaimer, not a quality grade, and the gap between what a peptide vial's label implies and what's actually inside it can be the difference between a clean reagent and a contaminated injectable.

A COA is the closest thing a research peptide has to a fingerprint and a polygraph at once, but only if you know which numbers prove identity, which prove purity, and which prove nothing at all.

"Compounded" is not a synonym for "FDA-approved", and when a product is labeled semaglutide sodium or semaglutide acetate, the FDA says you may not be getting the same active ingredient at all.

A lyophilized peptide is a fragile, dehydrated protein. The wrong wrist-flick, the wrong water, or the wrong shelf can quietly wreck it before the powder even finishes dissolving.

Growth peptides work by turning up the same GH/IGF-1 signal that, in high concentrations, is linked to cancer biology. Here is what the evidence actually shows, what it does not, and why your personal history changes the math.

A peptide can be chemically ruined and look completely normal. Understanding the four ways these molecules break down explains every storage rule you have ever been given, and why your eyes are the wrong instrument.

A handful of GLP-1 peptides have rewritten obesity medicine with double-digit weight loss in large randomized trials. Most other "fat-loss peptides" sold online are riding their coattails on animal data alone.

One is a class of amino-acid chains that includes some of the best-selling drugs on Earth; the other is a family of synthetic small molecules the FDA says cannot be legally sold at all. Here is where they actually diverge: in chemistry, mechanism, law, and evidence.

Four peptides, two mechanisms, and exactly one FDA approval: here's what the human evidence actually shows about GHRH analogues, ghrelin agonists, and the IGF-1 axis they all feed into.

They started as the same molecule in the same lab, but one became an FDA-approved prescription drug and the other became a gray-market tanning injection regulators keep warning against. Here's the honest science on both.

One hormone, two hormones, three: how the single-, dual-, and triple-receptor incretins stack up on mechanism, trial evidence, and approval status, and why "more receptors" is a hypothesis the data is still testing.

"Peptide" isn't one legal category. It's at least five, and the same molecule can be an approved medicine, a banned doping agent, and an illegal-to-sell "research chemical" all at once. Here's how to read the map.

BPC-157 is prohibited in sport, unapproved as a drug, and freely purchasable online. Those three facts are not a contradiction, and untangling them explains what "research use only" is really doing.

A rat study, a glossy certificate, and a shredded influencer are not evidence of human safety. Here's what the actual data says about the seven claims the peptide internet keeps repeating.